Proceedings of the National Academy of Sciences · 1993 · 56 citations · 11 references
Life SciencesEndocrinologyMolecular BiologyAutoimmunityImmunopathologyMonoclonal AntibodiesAutoantibodiesDiabetes MellitusImmunoglobulin FunctionPancreatic EndocrinologyPancreatic HormonesGlucose AbsorptionGlucose Transporter 2Islet AutoimmunityIslet Cell DysfunctionIslet Cell PhysiologyPancreatic Islet Cells
Purified immunoglobulin G (IgG) from the serum of patients with insulin-dependent diabetes mellitus (IDDM) of recent onset inhibits high-Km uptake of 3-O-methyl-beta-D-glucose by rat pancreatic islets. To determine if the inhibition is the result of antibodies against GLUT-2, the high-Km glucose transporter of beta cells, we incubated IDDM sera with rat islet cells and with AtT-20ins cells transfected to express GLUT-2. IDDM sera inhibited glucose uptake in islet cells and in GLUT-2-expressing AtT-20ins cells but not in AtT-20ins cells transfected to express the low-Km isoform, GLUT-1. In 24 of 30 (77%) patients with newly diagnosed IDDM, IgG binding as measured by immunofluorescence and flow cytometry of the cells transfected to express GLUT-2 was > 2 standard deviations from the mean of the nondiabetic population; 29 of 31 (96%) of nondiabetic children were negative (P < 0.0001). Increased IgG binding could be removed by absorption with GLUT-2-expressing cells but not with GLUT-1-expressing cells. We conclude that most patients with IDDM of recent onset have autoantibodies to GLUT-2.
11
Insulin Antibodies in Insulin-Dependent Diabetics Before Insulin Treatment
Jerry P. Palmer, Christopher M. Asplin, Peter Clemons et al. · Science · 1983 · 1.1K citations
Medicine, Endocrinology, Immunology +15
John H. Johnson, Christopher B. Newgard, Joseph L. Milburn et al. · Journal of Biological Chemistry · 1990 · 205 citations · Full text